logo
logo

Ramm Pharma Corp. Acquires Leading European Hemp Manufacturer Hempoland

Sep 06, 2022about 3 years ago

Acquiring Company

RAMM PHARMA

Acquired Company

CONTECHS

BasildonCannabisPharmaceuticalBiotechnologyManufacturing

Description

RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), is pleased to announce that today it has acquired all of the issued and outstanding shares of HemPoland S.p.a. Z.o.o. (“HemPoland”) from The Green Organic Dutchman Holdings Ltd. (CSE: TGOD) for cash consideration of C$1.2 million.

Company Information

Company

RAMM PHARMA

Location

José Belloni

About

RAMM PHARMA Corp is a company listed on the stock market. It was the target of an acquisition involving a significant number of its common shares. The company is engaged in the pharmaceutical sector.

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed